Why a pomegranate?
Open accessThe DOI matches its Crossref record.
Abstract
Objective To examine health professionals9 experiences of and attitudes towards the provision of chemotherapy to patients with end stage cancer. Design Purposive, qualitative design based on in-depth interviews. Setting Oncology departments at university hospitals and general hospitals in the Netherlands. Participants 14 physicians and 13 nurses who cared for patients with metastatic cancer. Results Physicians and nurses reported trying to inform patients fully about their poor prognosis and treatment options. They would carefully consider the (side) effects of chemotherapy and sometimes doubted whether further treatment would contribute to patients9 quality of life. Both groups considered the patients9 wellbeing to be important, and physicians seemed inclined to try to preserve this by offering further chemotherapy, often followed by the patient. Nurses were more often inclined to express their doubts about further treatment, preferring to allow patients to make the best use of the time that is left. When confronted with a treatment dilemma and a patient9s wish for treatment, physicians preferred to make compromises, such as by “trying out one dose.” Discussing death or dying with patients while at the same time administering chemotherapy was considered contradictory as this could diminish the patients9 hope. Conclusions The trend to greater use of chemotherapy at the end of life could be explained by patients9 and physicians9 mutually reinforcing attitudes of “not giving up” and by physicians9 broad interpretation of patients9 quality of life, in which taking away patients9 hope by withholding treatment is considered harmful. To rebalance the ratio of quantity of life to quality of life, input from other health professionals, notably nurses, may be necessary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Lansky, E. P., & Newman, R. A. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.09.006 · Cited by 1,290
Aviram, M., Rosenblat, M., Gaitini, D., Nitecki, S., Hoffman, A., Dornfeld, L., Volkova, N., Presser, D., Attias, J., Liker, H., et al. (2004) · Clinical Nutrition · doi:10.1016/j.clnu.2003.10.002 · Cited by 622
Aviram, M., & Dornfeld, L. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00412-9 · Cited by 431
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
Malik, A., Afaq, F., Sarfaraz, S., Adhami, V. M., Syed, D. N., & Mukhtar, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505870102 · Cited by 401
Tzulker, R., Glazer, I., Bar-Ilan, I., Holland, D., Aviram, M., & Amir, R. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf071413n · Cited by 391
Metadata
- Authors
- Langley, P.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2000-11-04
- Volume
- 321
- Issue
- 7269
- Pages
- 1153-1154
- ISSN
- 0959-8138 (ISSN-L)
- OpenAlex
- W2079332689
- Cited by
- 119
- References
- 0
- FWCI
- 1.13
- Type
- journal article
- Language
- hu
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Why a pomegranate? https://app.cochat.ai/papers/10.1136/bmj.321.7269.1153
- The paper
- Langley, P. (2000). Why a pomegranate? BMJ. https://doi.org/10.1136/bmj.321.7269.1153
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.